Lexiaochuan Wen, MD
Lexiaochuan Wen, MD
Specialty: Urology
Program: Genitourinary Oncology
Language(s): English
-
Publications
- Fazili A, Jazayeri SB, Rose KM, Guske C, Wen L, Durant A, Prunty M, Bukavina L, Tyson MD, Grass GD, Xu H, Spiess PE, Gilbert SM, Sexton WJ, Zemp L, Pessoa RR, Poch M, Lerner SP, Li R. Cisplatin-ineligible patients with muscle-invasive bladder cancer demonstrate poor long-term survival following immediate radical cystectomy. BJU Int. 2026 Jan.137(1):181-188. Pubmedid: 40932312.
- Wen L, Li R. Editorial Comment. J Urol. 2025 Jul.214(1):31. Pubmedid: 40197089.
- Wen L, Miyagi H, Spiess PE, Yu A, Mendelsohn CL, Tan WS, Psutka SP, Lerner SP, Cheng L, Dyrskjøt L, Meeks JJ, Shariat SF, Gontero P, Pradere B, Steinberg GD, Kamat AM, Li R. Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies. Nat Rev Urol. 2025 Dec.22(12):846-861. Pubmedid: 40931081.
- Jazayeri SB, DiNatale RG, Guske C, Harrs C, Linscott J, Xu H, Davaro F, Wen L, Spiess PE, Sexton WJ, Gilbert SM, Zemp L, Poch MA, Li R. Bacillus Calmette-Guérin-exposed Non-muscle-invasive Bladder Cancer: Survival Benchmarks, Bladder-sparing Strategies, and Implications for Trial Design. Eur Urol Focus. 2025 Dec. Pubmedid: 41421932.
- Fazili A, Sirard RB, Thompson Z, Wen L, Jazayeri SB, Naso C, Freamon C, Tighe J, Chahoud J, Spiess PE. Early postoperative visits improve outcomes in inguinal lymph node dissection for penile cancer. BJU Int. 2025 Aug.136(2):289-296. Pubmedid: 40318206.
- Köhler TS, Wen L, Wilson SK. Penile implant infection part 3: the changing spectrum of treatment. Int J Impot Res. 2023 Sep.35(6):512-518. Pubmedid: 33750937.
- Park SH, Wilson SK, Wen L. Subcoronal Incision for Inflatable Penile Prosthesis Does Not Risk Glans Necrosis. J Urol. 2023 Oct.210(4):678-687. Pubmedid: 37490615.
- Khera M, Mulcahy J, Wen L, Wilson SK. Is there still a place for malleable penile implants in the United States? Wilson's Workshop #18. Int J Impot Res. 2023 Mar.35(2):82-89. Pubmedid: 33273715.
- Wilson SK, Wen L, Rossello M, Maria P, Carrion R, Perito P, Ralph D, Antonini G, Carvajal A, Ozturk MI, Chung E. Initial safety outcomes for the Rigicon Infla10® inflatable penile prosthesis. BJU Int. 2023 Jun.131(6):729-733. Pubmedid: 36633050.
- Wilson SK, Wen L, Egydio PH. Evolution of techniques for aesthetic penile enlargement during prosthesis placement: a chronicle of the Egydio non-grafting strategy. Int J Impot Res. 2023 Jun.35(4):1-8. Pubmedid: 33273716.
- Wen L, Christine B, Köhler T, Wilson SK. Implant practice building: tenets to growing a successful and rewarding practice. Int J Impot Res. 2023 Aug.35(5):419-427. Pubmedid: 33328619.
- Mulcahy JJ, Tatem A, Wen L, Wilson SK. The last survivor of unitary and two-piece inflatables-the Ambicor. Does it still have a role in today's implant marketplace?. Int J Impot Res. 2022 Sep.34(6):511-519. Pubmedid: 33402721.
- Perito P, Mulcahy J, Wen L, Wilson SK. Nuances of infrapubic incision for inflatable penile prosthesis. Int J Impot Res. 2022 Sep.34(6):524-533. Pubmedid: 33340030.
- Park SH, Wen L, Mulcahy J, Wilson SK. Nuances of subcoronal inflatable penile prosthesis for physicians accustomed to penoscrotal approach. Int J Impot Res. 2022 Dec.34(8):739-745. Pubmedid: 32848208.
- Wen L, Britton CJ, Garje R, Darbro BW, Packiam VT. The emerging role of somatic tumor sequencing in the treatment of urothelial cancer. Asian J Urol. 2021 Oct.8(4):391-399. Pubmedid: 34765446. Pmcid: PMC8566359.
- Wen L, Köhler TS, Helo S. A narrative review of the management of benign prostatic hyperplasia in patients undergoing penile prosthesis surgery. Transl Androl Urol. 2021 Jun.10(6):2695-2704. Pubmedid: 34295754. Pmcid: PMC8261430.
- Mulcahy JJ, Köhler TS, Wen L, Wilson SK. Penile implant infection prevention part II: device coatings have changed the game. Int J Impot Res. 2020 Dec.33(8):801-807. Pubmedid: 32770140. Pmcid: PMC8776559.
- Köhler TS, Wen L, Wilson SK. Penile implant infection prevention part 1: what is fact and what is fiction? Wilson's Workshop #9. Int J Impot Res. 2020 Dec.33(8):785-792. Pubmedid: 32694583.
- Liu Y, Horn JL, Banda K, Goodman AZ, Lim Y, Jana S, Arora S, Germanos AA, Wen L, Hardin WR, Yang YC, Coleman IM, Tharakan RG, Cai EY, Uo T, Pillai SPS, Corey E, Morrissey C, Chen Y, Carver BS, Plymate SR, Beronja S, Nelson PS, Hsieh AC. The androgen receptor regulates a druggable translational regulon in advanced prostate cancer. Sci Transl Med. 2019 Jul.11(503). Pubmedid: 31366581. Pmcid: PMC6746573.
- Winters BR, Wen L, Holt SK, Dash A, Gore JL, Schade GR, Wright JL. Does the Diagnosis of Bladder Cancer Lead to Higher Rates of Smoking Cessation? Findings from the Medicare Health Outcomes Survey. J Urol. 2019 Aug.202(2):241-246. Pubmedid: 30835630.
- Hsieh AC, Nguyen HG, Wen L, Edlind MP, Carroll PR, Kim W, Ruggero D. Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors. Sci Signal. 2015 Nov.8(403):ra116. Pubmedid: 26577921. Pmcid: PMC4739654.
-
Grants
- Title: Utilizing Cell-Free Urine Tumor DNA to Predict Response and Resistance to TAR-210
Award Number:
Sponsor: American Urological Association (AUA)
Wen, L. (PD/PI)
- Title: Utilizing Cell-Free Urine Tumor DNA to Predict Response and Resistance to TAR-210
-
Patient Comments
0 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Learn more about our patient satisfaction surveyComments
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
Learn more about our patient comments
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:
Learn more about our patient satisfaction survey, ratings and comments